Diamonds and Dogs
July 9th, 2010Diamond
Google shares were up early in the trading day as a licensing agreement with China was finally made. The problem stemmed from Google no longer willing to obey China's self censorship rules due to the government putting new limits on free speech and Google suspecting multiple cyber-attacks to have begun in China. China has the most internet users in the world so it comes as no surprise that the contract was worthwhile for Google. Shares were up 2.54% or $11.6 to 468.16.
GlaxoSmithKline PLC Common Stock, GSK
Not too many dogs in the early market but one that has emerged is GlaxoSmithKline. This pharmaceutical company has its leading diabetes drug, Avandia, being reviewed by European regulators. The drug is suspected to be causing or exacerbating cardiovascular problems in many its users. The shares for the stock fell almost 1%, “ .34, to $34.57.